Dasatinib Active Not Recruiting Phase 2 Trials for Estrogen Receptor Negative / Endometrial Clear Cell Adenocarcinoma / Recurrent Ovarian Carcinoma / Recurrent Primary Peritoneal Carcinoma / Recurrent Uterine Corpus Carcinoma / Recurrent Fallopian Tube Carcinoma / Ovarian Clear Cell Cystadenocarcinoma Treatment